Its latest quarterly revenue reached 241.06M, representing a year-over-year decrease of 17.84%, while its net profit experienced a year-over-year decrease of 770.61%.
The current valuation score of Cross Country Healthcare Inc is 8.76. Its current P/E ratio is -4.35, which is -1792.82% below the recent high of 73.61 and -7998.21% above the recent low of -352.14.
The current earnings forecast score of Cross Country Healthcare Inc is 6.00. The average price target is 11.00, with a high of 18.61 and a low of 8.65.
The current price momentum score of Cross Country Healthcare Inc is 1.06. Currently, the stock price is trading between the resistance level at 13.29 and the support level at 13.18, making it suitable for range-bound swing trading.
The latest institutional shareholding proportion is 88.70%, representing a quarter-over-quarter decrease of 30.39%.
The current risk assessment score of Cross Country Healthcare Inc is 3.99. The company's beta value is 0.44. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.